Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
1,100.571,098.941,103.801,084.24
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
605.15605.15606.69602.76
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
1,195.191,204.711,221.691,204.71
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
1,739.911,734.501,734.501,710.67
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
638.56640.21645.32638.69
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
831.57840.48844.16834.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
213.36213.36215.79212.77
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
3,234.183,171.863,195.363,145.46
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
935.65937.31941.44933.16
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
1,449.261,454.771,462.651,447.95
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
2,382.452,371.192,380.452,362.86
A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
R$77.00
0.00%
(0.00) 1D
Apr 28, 10:52:23 AM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for A1LN34...
Mkt. cap
40.31B
Avg. vol.
4.62K
Volume
0.00
52-wk high
R$132.40
52-wk low
R$72.84
Shares outstanding
133.43M
No. of employees
2K
News stories
From sources across the web
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals Inc Bdr
CEO-
Employees2.5K
FoundedJun 14, 2002
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
594.19M
773.69M
1.25B
1.10B
Cost of goods sold
71.04M
142.95M
200.15M
267.72M
Cost of revenue
71.04M
142.95M
200.15M
267.72M
Research and development expenses
265.12M
323.62M
358.81M
372.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
239.95M
323.31M
322.08M
325.37M
Operating expense
505.07M
646.94M
680.89M
697.59M
Total operating expenses
576.11M
789.89M
881.04M
965.32M
Operating income
18.08M
-16.20M
367.98M
131.72M
Other non operating income
-48.74M
-5.05M
-74.15M
92.98M
EBT including unusual items
-41.60M
-35.36M
238.97M
161.14M
EBT excluding unusual items
-40.64M
-34.01M
278.12M
121.99M
Income tax expense
15.88M
30.92M
-12.12M
-25.28M
Effective tax rate
-38.18%
-87.45%
-5.07%
-15.69%
Other operating expenses
-
-
-
-
Net income
-57.48M
-66.28M
251.08M
186.42M
Net profit margin
-9.67%
-8.57%
20.10%
16.99%
Earnings per share
-0.01
0.32
2.90
1.25
Interest and investment income
28.67M
27.49M
28.68M
26.63M
Interest expense
-38.65M
-40.25M
-44.40M
-129.34M
Net interest expenses
-9.97M
-12.76M
-15.72M
-102.71M
Depreciation and amortization charges
-
-
-
-
EBITDA
32.48M
-2.26M
381.78M
145.22M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more